UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 5, 2019
AMETEK, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 1-12981 | 14-1682544 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
1100 Cassatt Road, Berwyn, Pennsylvania |
19312 | |||
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (610) 647-2121
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 5, 2019, AMETEK, Inc. (the Company) issued a press release announcing its financial results for the three months and year ended December 31, 2018. A copy of the release is furnished as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished pursuant to Item 2.02 of Form 8-K.
The information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
Description | |
99.1 | Press release, dated February 5, 2019, AMETEK Announces Record Fourth Quarter and Full Year Results and Issues 2019 Guidance |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMETEK, Inc. | ||||||
February 5, 2019 | By: | /s/ Thomas M. Montgomery | ||||
Name: Thomas M. Montgomery | ||||||
Title: Senior Vice President Comptroller |
Exhibit 99.1
AMETEK ANNOUNCES RECORD FOURTH QUARTER AND
FULL YEAR RESULTS
- | Reports fourth quarter sales up 11% over prior year |
- | Reports GAAP earnings of $0.91 per diluted share; delivers adjusted earnings of $0.86 per diluted share, up 23% over 2017 adjusted earnings |
- | Provides 2019 adjusted earnings guidance of $3.95 to $4.05 per diluted share |
BERWYN, PA, FEBRUARY 5, 2019 AMETEK, Inc. (NYSE: AME) today announced its financial results for the fourth quarter and full year ended December 31, 2018.
AMETEKs fourth quarter 2018 sales were a record $1.27 billion, up 11% compared to the fourth quarter of 2017, with organic sales growth of 5%. Operating income increased 14% to a record $282.0 million, and operating margins expanded to 22.2%, up 50 basis points over the prior years adjusted results.
On a GAAP basis, fourth quarter earnings per diluted share were $0.91. Excluding an after-tax gain of $11.8 million, or $0.05 per diluted share, related to the finalization of the impact of the 2017 Tax Cuts and Jobs Act, fourth quarter earnings were $0.86 per diluted share, an increase of 23% over the prior years adjusted earnings. A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying this release and on the AMETEK website.
AMETEK completed an outstanding year with record results in the fourth quarter, said David A. Zapico, AMETEK Chairman and Chief Executive Officer. Our businesses again delivered strong organic sales growth and outstanding operating performance driving robust sales and earnings growth in the quarter.
Additionally, our businesses continue to generate excellent levels of cash flow with operating cash flow in the fourth quarter a record $296 million, added Mr. Zapico. We remain focused on deploying our free cash flow on strategic acquisitions having deployed a record $1.1 billion of capital on acquisitions in 2018, including $750 million on three acquisitions in the fourth quarter. We also deployed $364 million on share repurchases in the quarter.
For the full year, AMETEKs sales were a record $4.8 billion, an increase of 13% over 2017, and organic sales growth was 7%. Operating income in 2018 was a record $1.08 billion, up 16%, and operating income margins were 22.2%, expanding 70 basis points over 2017s adjusted results.
Page 1 |
On a GAAP basis, earnings were $3.34 per diluted share. Excluding the after-tax gain of $0.05 per diluted share, 2018 earnings were $3.29 per diluted share, a 26% increase over 2017s adjusted earnings.
Electronic Instruments Group (EIG)
Fourth quarter EIG sales were a record $826.0 million, up 11% over the fourth quarter of 2017. EIG operating income was a record $214.6 million in the quarter, up 11% over the prior-year periods adjusted results, and operating margins were 26.0%.
EIG finished the year with an outstanding fourth quarter, delivering excellent sales and operating income growth. In addition to solid organic growth and excellent operating performance, we completed five acquisitions across EIG in 2018, noted Mr. Zapico.
Electromechanical Group (EMG)
EMG sales in the fourth quarter were $445.3 million, up 11% over the same quarter in 2017. EMGs fourth quarter operating income was $85.8 million, an 18% increase, and operating margins were 19.3%, expanding 110 basis points over the prior years adjusted results.
EMG also capped the year with exceptional results in the fourth quarter. Sales grew by double digits on strong, broad-based organic sales growth and contributions from the acquisition of FMH Aerospace. EMG continues to deliver excellent results through our Operational Excellence initiatives, which resulted in a sharp increase in operating income during the quarter, commented Mr. Zapico.
2019 Outlook
Going forward, AMETEK will report and provide guidance on an adjusted diluted earnings per share basis that adds back non-cash, after-tax, acquisition related intangible amortization. The company believes this non-GAAP measure provides investors with a better understanding of its cash flows and core operating results and aligns more comparably to AMETEKs acquisitive peer companies. A reconciliation of our GAAP to non-GAAP results and guidance will be included in financial tables accompanying our press releases.
Our businesses delivered outstanding performance in 2018, positioning us well for continued success in 2019. The AMETEK Growth Model, which combines our four growth strategies of operational excellence, new product development, global and market expansion, and strategic acquisitions, along with a disciplined focus on cash generation and capital deployment continues to provide a scalable platform to drive long-term, sustainable growth, noted Mr. Zapico.
In 2019, we expect overall sales to be up high single digits on a percentage basis compared to 2018, driven by contributions from recent acquisitions, and 3% to 5% organic sales growth. On a GAAP basis, full year earnings per diluted share are expected to be in the range of $3.52 to $3.62. Adjusted earnings per diluted share are expected to be in the range of $3.95 to $4.05, an increase of 8% to 11% over the prior years comparable basis, he added.
Page 2 |
For the first quarter of 2019, sales are expected to be up high single digits on a percentage basis compared to the prior-year. On a GAAP basis, earnings per diluted share are expected to be in the range of $0.84 to $0.86. Adjusted earnings per diluted share are anticipated to be in the range of $0.95 to $0.97, up 9% to 11% over the prior year comparable basis, concluded Mr. Zapico.
Conference Call
AMETEK will webcast its fourth quarter 2018 investor conference call on Tuesday, February 5, 2019, beginning at 8:30 AM ET. The live audio webcast will be available and later archived in the Investors section of www.ametek.com.
Corporate Profile
AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with sales of approximately $5.0 billion. AMETEKs growth model is based on four key strategies: Operational Excellence, Strategic Acquisitions, Global & Market Expansion and New Products. AMETEKs objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500 Index.
Forward-looking Information
Statements in this news release relating to future events, such as AMETEKs expected business and financial performance are forward-looking statements. Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include AMETEKs ability to consummate and successfully integrate future acquisitions; risks associated with international sales and operations; AMETEKs ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve. A detailed discussion of these and other factors that may affect our future results is contained in AMETEKs filings with the U.S. Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.
Contact:
AMETEK, Inc.
Kevin Coleman
Vice President, Investor Relations
1100 Cassatt Road
Berwyn, Pennsylvania 19312
kevin.coleman@ametek.com
Phone: 610.889.5247
Page 3 |
AMETEK, Inc.
Consolidated Statement of Income
(In thousands, except per share amounts)
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
(Unaudited) | (Unaudited) | |||||||||||||||
Net sales |
$ | 1,271,328 | $ | 1,143,085 | $ | 4,845,872 | $ | 4,300,170 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses: |
||||||||||||||||
Cost of sales |
835,268 | 769,650 | 3,186,310 | 2,861,370 | ||||||||||||
Selling, general and administrative |
154,040 | 146,849 | 584,022 | 535,180 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
989,308 | 916,499 | 3,770,332 | 3,396,550 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income |
282,020 | 226,586 | 1,075,540 | 903,620 | ||||||||||||
Other expenses: |
||||||||||||||||
Interest expense |
(20,319 | ) | (24,252 | ) | (82,180 | ) | (98,029 | ) | ||||||||
Other, net |
(2,931 | ) | (4,809 | ) | (5,615 | ) | (8,862 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before income taxes |
258,770 | 197,525 | 987,745 | 796,729 | ||||||||||||
Provision (benefit) for income taxes |
47,250 | (41,007 | ) | 209,812 | 115,259 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
$ | 211,520 | $ | 238,532 | $ | 777,933 | $ | 681,470 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted earnings per share |
$ | 0.91 | $ | 1.03 | $ | 3.34 | $ | 2.94 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic earnings per share |
$ | 0.92 | $ | 1.03 | $ | 3.37 | $ | 2.96 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average common shares outstanding: |
||||||||||||||||
Diluted shares |
231,333 | 232,534 | 232,712 | 231,845 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic shares |
229,611 | 230,770 | 230,823 | 230,229 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Dividends per share |
$ | 0.14 | $ | 0.09 | $ | 0.56 | $ | 0.36 | ||||||||
|
|
|
|
|
|
|
|
AMETEK, Inc.
Information by Business Segment
(In thousands)
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
(Unaudited) | (Unaudited) | |||||||||||||||
Net sales: |
||||||||||||||||
Electronic Instruments |
$ | 826,034 | $ | 741,516 | $ | 3,028,959 | $ | 2,690,554 | ||||||||
Electromechanical |
445,294 | 401,569 | 1,816,913 | 1,609,616 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Consolidated net sales |
$ | 1,271,328 | $ | 1,143,085 | $ | 4,845,872 | $ | 4,300,170 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Income: |
||||||||||||||||
Segment operating income: |
||||||||||||||||
Electronic Instruments |
$ | 214,641 | $ | 189,642 | $ | 782,144 | $ | 671,646 | ||||||||
Electromechanical |
85,846 | 60,758 | 363,765 | 306,779 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total segment operating income |
300,487 | 250,400 | 1,145,909 | 978,425 | ||||||||||||
Corporate administrative and other expenses |
(18,467 | ) | (23,814 | ) | (70,369 | ) | (74,805 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Consolidated operating income |
$ | 282,020 | $ | 226,586 | $ | 1,075,540 | $ | 903,620 | ||||||||
|
|
|
|
|
|
|
|
Page 4 |
AMETEK, Inc.
Condensed Consolidated Balance Sheet
(In thousands)
December 31, | December 31, | |||||||
2018 | 2017 | |||||||
(Unaudited) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 353,975 | $ | 646,300 | ||||
Receivables, net |
732,839 | 668,176 | ||||||
Inventories, net |
624,744 | 540,504 | ||||||
Other current assets |
124,586 | 79,675 | ||||||
|
|
|
|
|||||
Total current assets |
1,836,144 | 1,934,655 | ||||||
Property, plant and equipment, net |
554,130 | 493,296 | ||||||
Goodwill |
3,612,033 | 3,115,619 | ||||||
Other intangibles, investments and other assets |
2,659,981 | 2,252,494 | ||||||
|
|
|
|
|||||
Total assets |
$ | 8,662,288 | $ | 7,796,064 | ||||
|
|
|
|
|||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Short-term borrowings and current portion of long-term debt, net |
$ | 358,876 | $ | 308,123 | ||||
Accounts payable and accruals |
899,828 | 830,540 | ||||||
|
|
|
|
|||||
Total current liabilities |
1,258,704 | 1,138,663 | ||||||
Long-term debt, net |
2,273,837 | 1,866,166 | ||||||
Deferred income taxes and other long-term liabilities |
887,825 | 763,602 | ||||||
Stockholders equity |
4,241,922 | 4,027,633 | ||||||
|
|
|
|
|||||
Total liabilities and stockholders equity |
$ | 8,662,288 | $ | 7,796,064 | ||||
|
|
|
|
Page 5 |
AMETEK, Inc.
Reconciliations of GAAP to Non-GAAP Financial Measures
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
EIG Segment operating income (GAAP) |
$ | 214,641 | $ | 189,642 | $ | 782,144 | $ | 671,646 | ||||||||
Realignment costs |
| 4,534 | | 4,534 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted EIG Segment operating income (Non-GAAP) |
$ | 214,641 | $ | 194,176 | $ | 782,144 | $ | 676,180 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
EMG Segment operating income (GAAP) |
$ | 85,846 | $ | 60,758 | $ | 363,765 | $ | 306,779 | ||||||||
Realignment costs |
| 12,252 | | 12,252 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted EMG Segment operating income (Non-GAAP) |
$ | 85,846 | $ | 73,010 | $ | 363,765 | $ | 319,031 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income (GAAP) |
$ | 282,020 | $ | 226,586 | $ | 1,075,540 | $ | 903,620 | ||||||||
Realignment costs |
| 16,786 | | 16,786 | ||||||||||||
Charitable donations |
| 5,000 | | 5,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted Operating income (Non-GAAP) |
$ | 282,020 | $ | 248,372 | $ | 1,075,540 | $ | 925,406 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Provision for income taxes (GAAP) |
$ | 47,250 | $ | (41,007 | ) | $ | 209,812 | $ | 115,259 | |||||||
Income tax benefit on realignment costs |
| 3,821 | | 3,821 | ||||||||||||
Income tax benefit on charitable donations |
| 1,885 | | 1,885 | ||||||||||||
Net deferred tax revaluation due to Tax Reform(1) |
1,422 | 185,781 | 1,422 | 185,781 | ||||||||||||
Deemed repatriation of foreign earnings due to Tax Reform(1) |
10,398 | (94,191 | ) | 10,398 | (94,191 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted provision for income taxes (Non-GAAP) |
$ | 59,070 | $ | 56,289 | $ | 221,632 | $ | 212,555 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (GAAP) |
$ | 211,520 | $ | 238,532 | $ | 777,933 | $ | 681,470 | ||||||||
Realignment costs |
| 12,965 | | 12,965 | ||||||||||||
Charitable donations |
| 3,115 | | 3,115 | ||||||||||||
Net deferred tax revaluation due to Tax Reform(1) |
(1,422 | ) | (185,781 | ) | (1,422 | ) | (185,781 | ) | ||||||||
Deemed repatriation of foreign earnings due to Tax Reform(1) |
(10,398 | ) | 94,191 | (10,398 | ) | 94,191 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted Net income (Non-GAAP) |
$ | 199,700 | $ | 163,022 | $ | 766,113 | $ | 605,960 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted earnings per share (GAAP) |
$ | 0.91 | $ | 1.03 | $ | 3.34 | $ | 2.94 | ||||||||
Realignment costs |
| 0.07 | | 0.07 | ||||||||||||
Income tax benefit on realignment costs |
| (0.02 | ) | | (0.02 | ) | ||||||||||
Charitable donations |
| 0.02 | | 0.02 | ||||||||||||
Income tax benefit on charitable donations |
| (0.01 | ) | | (0.01 | ) | ||||||||||
Net deferred tax revaluation due to Tax Reform(1) |
(0.01 | ) | (0.80 | ) | (0.01 | ) | (0.80 | ) | ||||||||
Deemed repatriation of foreign earnings due to Tax Reform(1) |
(0.04 | ) | 0.41 | (0.04 | ) | 0.41 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted Diluted earnings per share (Non-GAAP) |
$ | 0.86 | $ | 0.70 | $ | 3.29 | $ | 2.61 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
EIG Segment operating margin (GAAP) |
26.0 | % | 25.6 | % | 25.8 | % | 25.0 | % | ||||||||
Realignment costs |
| 0.6 | | 0.1 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted EIG Segment operating margin (Non-GAAP) |
26.0 | % | 26.2 | % | 25.8 | % | 25.1 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
EMG Segment operating margin (GAAP) |
19.3 | % | 15.1 | % | 20.0 | % | 19.1 | % | ||||||||
Realignment costs |
| 3.1 | | 0.8 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted EMG Segment operating margin (Non-GAAP) |
19.3 | % | 18.2 | % | 20.0 | % | 19.9 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income margin (GAAP) |
22.2 | % | 19.8 | % | 22.2 | % | 21.0 | % | ||||||||
Realignment costs |
| 1.5 | | 0.4 | ||||||||||||
Charitable donations |
| 0.4 | | 0.1 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted Operating income margin (Non-GAAP) |
22.2 | % | 21.7 | % | 22.2 | % | 21.5 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Effective tax rate (GAAP) |
18.3 | % | (20.8 | )% | 21.2 | % | 14.5 | % | ||||||||
Realignment costs |
| (0.2 | ) | | (0.1 | ) | ||||||||||
Charitable donations |
| 0.3 | | 0.1 | ||||||||||||
Net deferred tax revaluation due to Tax Reform(1) |
0.5 | 94.1 | 0.1 | 23.3 | ||||||||||||
Deemed repatriation of foreign earnings due to Tax Reform(1) |
4.0 | (47.7 | ) | 1.1 | (11.8 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted Effective tax rate (Non-GAAP) |
22.8 | % | 25.7 | % | 22.4 | % | 26.0 | % | ||||||||
|
|
|
|
|
|
|
|
Page 6 |
AMETEK, Inc.
Reconciliations of GAAP to Non-GAAP Financial Measures
(In thousands, except per share amounts)
(Unaudited)
Forecasted Diluted Earnings Per Share | ||||||||||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||||||||||
March 31, | December 31, | |||||||||||||||||||||||
Low | High | Low | High | |||||||||||||||||||||
2019 | 2019 | 2018 | 2019 | 2019 | 2018 | |||||||||||||||||||
Diluted earnings per share (GAAP) |
$ | 0.84 | $ | 0.86 | $ | 0.78 | $ | 3.52 | $ | 3.62 | $ | 3.34 | ||||||||||||
Pretax amortization of acquisition-related intangible assets |
0.14 | 0.14 | 0.12 | 0.57 | 0.57 | 0.49 | ||||||||||||||||||
Income tax benefit on amortization of acquisition-related intangible assets |
(0.03 | ) | (0.03 | ) | (0.03 | ) | (0.14 | ) | (0.14 | ) | (0.12 | ) | ||||||||||||
Net deferred tax revaluation due to Tax Reform (1) |
| | | | | (0.01 | ) | |||||||||||||||||
Deemed repatriation of foreign earnings due to Tax Reform (1) |
| | | | | (0.04 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Adjusted Diluted earnings per share (Non-GAAP) |
$ | 0.95 | $ | 0.97 | $ | 0.87 | $ | 3.95 | $ | 4.05 | $ | 3.66 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) - These amounts, which are based on reasonable estimates, will require further adjustments as additional guidance from the U.S. Department of Treasury is provided, the Companys assumptions change, or as further information and interpretations become available.
Use of Non-GAAP Financial Information
The Company supplements its consolidated financial statements presented on a U.S. generally accepted accounting principles (GAAP) basis with certain non-GAAP financial information to provide investors with greater insight, increased transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Reconciliation of non-GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial tables. These non-GAAP financial measures should be considered in addition to, and not as a replacement for, or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.
The Company believes that these measures provide useful information to investors by reflecting additional ways of viewing AMETEKs operations that, when reconciled to the comparable GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers. The items described above have been excluded from this measure because items of this nature and/or size occur with inconsistent frequency, occur for reasons that may be unrelated to AMETEKs commercial performance during the period and/or we believe are not indicative of AMETEKs ongoing operating costs or gains in a given period, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.
Page 7 |